A 4852
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill amends existing New Jersey law to clarify and expand the rules for prescribing Schedule II controlled dangerous substances through telemedicine and telehealth. It removes the requirement for an in-person examination before prescribing these medications, with some exceptions, and outlines specific requirements for providers, including licensing, record-keeping, and patient communication. The bill also addresses prescribing stimulants to minors and provides flexibility for certain patient populations, such as those undergoing cancer treatment or hospice care.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Joseph Vitale
Marisa Sweeney
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.